Experimental Vector-Based COVID-19 Vaccine Could Be Manufactured Like Flu Shots

A COVID-19 vaccine that can be produced locally in low- and middle-income countries is yielding promising results in early clinical trials, researchers say.
Reuters Health Information

source https://www.medscape.com/viewarticle/967520?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?